Skip to main content
SpringerLink
Log in

Modulation of metabolic brain function by bilateral subthalamic nucleus stimulation in the treatment of Parkinson’s disease

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) was proposed as an effective way to improve the symptoms of Parkinson’s disease (PD). We studied metabolic modulation in the brain by bilateral STN stimulation using FDG PET. Five PD patients (age 61.6 ± 3.9 years) at advanced stage were scanned under OFF and ON conditions of stimulation. Network analysis was used to evaluate the effect of stimulation on the expression of an abnormal Parkinson’s disease-related spatial covariance pattern (PDRP). In addition, statistical parametric mapping was used to assess the effect of this intervention on regional glucose metabolism. We found that bilateral STN DBS led to a significant reduction (P < 0.02) in the PDRP network activity on an individual subject basis between OFF and ON conditions, parallel to significant improvement (P < 0.002) of clinical symptoms in these patients. The treatment also decreased glucose metabolism in the right lentiform nucleus and cerebellum, and in the bilateral ventral thalamus and precuneus, but increased metabolism in the left midbrain and pons. This was consistent with the notion that clinical benefit in a PD patient was associated with the suppression of hyperactive motor circuitry following STN stimulation. These findings suggest that DBS is more likely to function by regulating the entire neural network rather than merely exciting or inhibiting certain nuclei.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Asanuma K, Tang C, Ma Y, Dhawan V, Mattis P, Edwards C, Kaplitt MG, Feigin A, Eidelberg D (2006) Network modulation in the treatment of Parkinson’s disease. Brain 129:2667–2678

    Article  PubMed  Google Scholar 

  2. Ceballos-Baumann AO, Boecker H, Bartenstein P, von Falkenhayn I, Riescher H, Conrad B, Moringlane JR, Alesch F (1999) A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity. Arch Neurol 56:997–1003

    Article  CAS  PubMed  Google Scholar 

  3. Djaldetti R, Ziv I, Melamed E (2006) The mystery of motor asymmetry in Parkinson’s disease. Lancet Neurol 5:796–802

    Article  PubMed  Google Scholar 

  4. Eckert T, Barnes A, Dhawan V, Frucht S, Gordon MF, Feigin AS, Eidelberg D (2005) FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 26:912–921

    Article  PubMed  Google Scholar 

  5. Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, Chaly T, Robeson W, Margouleff D, Przedborski S et al (1994) The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 14:783–801

    CAS  PubMed  Google Scholar 

  6. Eidelberg D, Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Chaly T, Robeson W, Dahl JR, Margouleff D (1995) Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET. J Nucl Med 36:378–383

    CAS  PubMed  Google Scholar 

  7. Eidelberg D, Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Silbersweig D, Stern E, Woods RP, Fazzini E, Dogali M, Beric A (1996) Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson’s disease. Ann Neurol 39:450–459

    Article  CAS  PubMed  Google Scholar 

  8. Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, Olanow CW, Tanner C, Marek K (2004) Levodopa and the progression of Parkinson’s disease. N Engl J Med 351:2498–2508

    Article  CAS  PubMed  Google Scholar 

  9. Feigin A, Fukuda M, Dhawan V, Przedborski S, Jackson-Lewis V, Mentis MJ, Moeller JR, Eidelberg D (2001) Metabolic correlates of levodopa response in Parkinson’s disease. Neurology 57:2083–2088

    CAS  PubMed  Google Scholar 

  10. Feigin A, Kaplitt MG, Tang C, Lin T, Mattis P, Dhawan V, During MJ, Eidelberg D (2007) Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson’s disease. Proc Natl Acad Sci USA 104:19559–19564

    Article  CAS  PubMed  Google Scholar 

  11. Fukuda M, Mentis MJ, Ma Y, Dhawan V, Antonini A, Lang AE, Lozano AM, Hammerstad J, Lyons K, Koller WC, Moeller JR, Eidelberg D (2001) Networks mediating the clinical effects of pallidal brain stimulation for Parkinson’s disease: a PET study of resting-state glucose metabolism. Brain 124:1601–1609

    Article  CAS  PubMed  Google Scholar 

  12. Gross C, Rougier A, Guehl D, Boraud T, Julien J, Bioulac B (1997) High-frequency stimulation of the globus pallidus internalis in Parkinson’s disease: a study of seven cases. J Neurosurg 87:491–498

    Article  CAS  PubMed  Google Scholar 

  13. Hilker R, Voges J, Weisenbach S, Kalbe E, Burghaus L, Ghaemi M, Lehrke R, Koulousakis A, Herholz K, Sturm V, Heiss WD (2004) Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson’s disease. J Cereb Blood Flow Metab 24:7–16

    Article  CAS  PubMed  Google Scholar 

  14. Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M, Dhawan V, Eidelberg D (2007) Changes in network activity with the progression of Parkinson’s disease. Brain 130:1834–1846

    Article  PubMed  Google Scholar 

  15. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184

    Article  CAS  PubMed  Google Scholar 

  16. Limousin P, Greene J, Pollak P, Rothwell J, Benabid AL, Frackowiak R (1997) Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson’s disease. Ann Neurol 42:283–291

    Article  CAS  PubMed  Google Scholar 

  17. Limousin P, Pollak P, Benazzouz A, Hoffmann D, Broussolle E, Perret JE, Benabid AL (1995) Bilateral subthalamic nucleus stimulation for severe Parkinson’s disease. Mov Disord 10:672–674

    Article  CAS  PubMed  Google Scholar 

  18. Lin TP, Carbon M, Tang C, Mogilner AY, Sterio D, Beric A, Dhawan V, Eidelberg D (2008) Metabolic correlates of subthalamic nucleus activity in Parkinson’s disease. Brain 131:1373–1380

    Article  PubMed  Google Scholar 

  19. Lozano AM, Lang AE, Levy R, Hutchison W, Dostrovsky J (2000) Neuronal recordings in Parkinson’s disease patients with dyskinesias induced by apomorphine. Ann Neurol 47:S141–S146

    Article  CAS  PubMed  Google Scholar 

  20. Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D (2007) Abnormal metabolic network activity in Parkinson’s disease: test-retest reproducibility. J Cereb Blood Flow Metab 27:597–605

    Article  PubMed  Google Scholar 

  21. Neal JW, Pearson RC, Powell TP (1990) The ipsilateral corticocortical connections of area 7 with the frontal lobe in the monkey. Brain Res 509:31–40

    Article  CAS  PubMed  Google Scholar 

  22. Pahwa R, Wilkinson S, Smith D, Lyons K, Miyawaki E, Koller WC (1997) High-frequency stimulation of the globus pallidus for the treatment of Parkinson’s disease. Neurology 49:249–253

    CAS  PubMed  Google Scholar 

  23. Parent A, Hazrati LN (1995) Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 20:128–154

    Article  CAS  PubMed  Google Scholar 

  24. Pollak P, Benabid AL, Limousin P, Benazzouz A, Hoffmann D, Le Bas JF, Perret J (1996) Subthalamic nucleus stimulation alleviates akinesia and rigidity in parkinsonian patients. Adv Neurol 69:591–594

    CAS  PubMed  Google Scholar 

  25. Strafella AP, Dagher A, Sadikot AF (2003) Cerebral blood flow changes induced by subthalamic stimulation in Parkinson’s disease. Neurology 60:1039–1042

    PubMed  Google Scholar 

  26. Su PC, Ma Y, Fukuda M, Mentis MJ, Tseng HM, Yen RF, Liu HM, Moeller JR, Eidelberg D (2001) Metabolic changes following subthalamotomy for advanced Parkinson’s disease. Ann Neurol 50:514–520

    Article  CAS  PubMed  Google Scholar 

  27. Taktakishvili O, Sivan-Loukianova E, Kultas-Ilinsky K, Ilinsky IA (2002) Posterior parietal cortex projections to the ventral lateral and some association thalamic nuclei in Macaca mulatta. Brain Res Bull 59:135–150

    PubMed  Google Scholar 

  28. Trost M, Su S, Su P, Yen RF, Tseng HM, Barnes A, Ma Y, Eidelberg D (2006) Network modulation by the subthalamic nucleus in the treatment of Parkinson’s disease. Neuroimage 31:301–307

    Article  PubMed  Google Scholar 

  29. Vafaee MS, ØStergaard K, Sunde N, Gjedde A, Dupont E, Cumming P (2004) Focal changes of oxygen consumption in cerebral cortex of patients with Parkinson’s disease during subthalamic stimulation. Neuroimage 22:966–974

    Article  CAS  PubMed  Google Scholar 

  30. Windels F, Bruet N, Poupard A, Urbain N, Chouvet G, Feuerstein C, Savasta M (2000) Effects of high frequency stimulation of subthalamic nucleus on extracellular glutamate and GABA in substantia nigra and globus pallidus in the normal rat. Eur J Neurosci 12:4141–4146

    Article  CAS  PubMed  Google Scholar 

  31. Yeterian EH, Pandya DN (1985) Corticothalamic connections of the posterior parietal cortex in the rhesus monkey. J Comp Neurol 237:408–426

    Article  CAS  PubMed  Google Scholar 

  32. Zuo CT, Guan YH, Li DY, Sun BM (2005) The effect of bilateral subthalamic nucleus stimulation in the treatment of advanced PD. J Nucl Med 46(Suppl 1):189

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Huashan Hospital, Fudan University, 12 Wulumuqi Middle Road, 200040, Shanghai, China

    Jian Wang

  2. Center for Neurosciences, Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, NY, 11030, USA

    YiLong Ma

  3. PET Center, Huashan Hospital, Fudan University, 12 Wulumuqi Middle Road, 200040, Shanghai, China

    ZheMin Huang, YiHui Guan & ChuanTao Zuo

  4. Department of Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University of Medicine, No. 197 Rui Jin Er Road, 200025, Shanghai, China

    BoMin Sun

Authors
  1. Jian Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. YiLong Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. ZheMin Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. BoMin Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. YiHui Guan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. ChuanTao Zuo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to ChuanTao Zuo.

Additional information

J. Wang and Y. Ma contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, J., Ma, Y., Huang, Z. et al. Modulation of metabolic brain function by bilateral subthalamic nucleus stimulation in the treatment of Parkinson’s disease. J Neurol 257, 72–78 (2010). https://doi.org/10.1007/s00415-009-5267-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-009-5267-3

Keywords

Search

Navigation